ResponseDX: Lung genetic test panel launched to detect EML4-ALK gene variants in lung cancer patients
Links shared publicly online about this topic.
- 1,055total visits
ResponseDX: Lung genetic test panel launched to detect EML4-ALK gene variants in lung cancer patients
Response Genetics Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, today announced that it has expanded its ResponseDX: Lung genetic test panel to detect the presence of EML4-ALK gene variants in lung cancer patients. EML4-ALK fusion genes are present in about four percent of tumors from patients with non-small cell lung cancer.
View full resource at news-medical.net
Tags: Genetic, Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Lung, Lab Test, Genes
Most Recently Shared on July 1, 2010 at 7:18 am By:
Lung Cancer News: ResponseDX: Lung genetic test panel launched to detect EML4-ALK gene variants in lung cancer pat... http://bit.ly/aEHE4T
Advertisement
